导航未来的多基因风险评分:来自儿童和青少年精神病学家的见解。

IF 2.2 3区 医学 Q2 PSYCHIATRY
Page M Trotter, Amanda R Merner, Lauren A Ginn, Abigail C Martinez, Ana L Battaglino, Kaitlynn P Craig, Jason Bach, Katherine J Freedberg, Takahiro Soda, Eric A Storch, Gabriel Lázaro-Muñoz, Stacey Pereira
{"title":"导航未来的多基因风险评分:来自儿童和青少年精神病学家的见解。","authors":"Page M Trotter, Amanda R Merner, Lauren A Ginn, Abigail C Martinez, Ana L Battaglino, Kaitlynn P Craig, Jason Bach, Katherine J Freedberg, Takahiro Soda, Eric A Storch, Gabriel Lázaro-Muñoz, Stacey Pereira","doi":"10.1007/s10578-025-01854-y","DOIUrl":null,"url":null,"abstract":"<p><p>Polygenic risk scores (PRS) are a method of calculating genetic risk for polygenic, or multi-gene, disorders. These scores have potential impacts in the realm of child and adolescent psychiatry, given the high prevalence of psychiatric disorders among youth. However, there are concerns about PRS implementation among key stakeholders, namely child and adolescent psychiatrists (CAP). We conducted interviews with 29 U.S.-based CAP to investigate clinician attitudes toward the use of PRS. The data herein correspond to a future scenario we provided CAP in which PRS are accurate and portable to patients of different racial and ethnic backgrounds. We found that CAP envisioned some utility for PRS in regards to clinical surveillance and treatment; however, several desired further research demonstrating that PRS positively impact patient outcomes before they would consider implementing PRS in-clinic. The most cited concern about PRS deployment was the potential for misinterpretation and misuse of PRS on the part of patients, families, corporate entities, and clinicians themselves. CAP emphasized the need for support in the form of testing infrastructure, clinical guidelines, and collaboration with the involvement of PRS experts, when considering PRS applications in the future.</p>","PeriodicalId":10024,"journal":{"name":"Child Psychiatry & Human Development","volume":" ","pages":""},"PeriodicalIF":2.2000,"publicationDate":"2025-05-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12212414/pdf/","citationCount":"0","resultStr":"{\"title\":\"Navigating the Future of Polygenic Risk Scores: Insights from Child and Adolescent Psychiatrists.\",\"authors\":\"Page M Trotter, Amanda R Merner, Lauren A Ginn, Abigail C Martinez, Ana L Battaglino, Kaitlynn P Craig, Jason Bach, Katherine J Freedberg, Takahiro Soda, Eric A Storch, Gabriel Lázaro-Muñoz, Stacey Pereira\",\"doi\":\"10.1007/s10578-025-01854-y\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>Polygenic risk scores (PRS) are a method of calculating genetic risk for polygenic, or multi-gene, disorders. These scores have potential impacts in the realm of child and adolescent psychiatry, given the high prevalence of psychiatric disorders among youth. However, there are concerns about PRS implementation among key stakeholders, namely child and adolescent psychiatrists (CAP). We conducted interviews with 29 U.S.-based CAP to investigate clinician attitudes toward the use of PRS. The data herein correspond to a future scenario we provided CAP in which PRS are accurate and portable to patients of different racial and ethnic backgrounds. We found that CAP envisioned some utility for PRS in regards to clinical surveillance and treatment; however, several desired further research demonstrating that PRS positively impact patient outcomes before they would consider implementing PRS in-clinic. The most cited concern about PRS deployment was the potential for misinterpretation and misuse of PRS on the part of patients, families, corporate entities, and clinicians themselves. CAP emphasized the need for support in the form of testing infrastructure, clinical guidelines, and collaboration with the involvement of PRS experts, when considering PRS applications in the future.</p>\",\"PeriodicalId\":10024,\"journal\":{\"name\":\"Child Psychiatry & Human Development\",\"volume\":\" \",\"pages\":\"\"},\"PeriodicalIF\":2.2000,\"publicationDate\":\"2025-05-17\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12212414/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Child Psychiatry & Human Development\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1007/s10578-025-01854-y\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"PSYCHIATRY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Child Psychiatry & Human Development","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s10578-025-01854-y","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"PSYCHIATRY","Score":null,"Total":0}
引用次数: 0

摘要

多基因风险评分(PRS)是一种计算多基因或多基因疾病遗传风险的方法。鉴于青少年中精神疾病的高患病率,这些分数在儿童和青少年精神病学领域具有潜在的影响。然而,在关键利益相关者,即儿童和青少年精神病学家(CAP)中,对PRS的实施存在担忧。我们对29个美国CAP进行了访谈,以调查临床医生对使用PRS的态度。本文的数据与我们提供的CAP的未来场景相对应,其中PRS对不同种族和民族背景的患者是准确和便携的。我们发现CAP设想了PRS在临床监测和治疗方面的一些效用;然而,在考虑在临床实施PRS之前,一些人希望进一步的研究证明PRS对患者的预后有积极的影响。关于PRS的部署,最令人担忧的是患者、家庭、公司实体和临床医生本身对PRS的误解和滥用的可能性。CAP强调,在考虑未来的PRS应用时,需要以测试基础设施、临床指南和与PRS专家合作的形式提供支持。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Navigating the Future of Polygenic Risk Scores: Insights from Child and Adolescent Psychiatrists.

Polygenic risk scores (PRS) are a method of calculating genetic risk for polygenic, or multi-gene, disorders. These scores have potential impacts in the realm of child and adolescent psychiatry, given the high prevalence of psychiatric disorders among youth. However, there are concerns about PRS implementation among key stakeholders, namely child and adolescent psychiatrists (CAP). We conducted interviews with 29 U.S.-based CAP to investigate clinician attitudes toward the use of PRS. The data herein correspond to a future scenario we provided CAP in which PRS are accurate and portable to patients of different racial and ethnic backgrounds. We found that CAP envisioned some utility for PRS in regards to clinical surveillance and treatment; however, several desired further research demonstrating that PRS positively impact patient outcomes before they would consider implementing PRS in-clinic. The most cited concern about PRS deployment was the potential for misinterpretation and misuse of PRS on the part of patients, families, corporate entities, and clinicians themselves. CAP emphasized the need for support in the form of testing infrastructure, clinical guidelines, and collaboration with the involvement of PRS experts, when considering PRS applications in the future.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
CiteScore
0.50
自引率
3.40%
发文量
174
期刊介绍: Child Psychiatry & Human Development is an interdisciplinary international journal serving the groups represented by child and adolescent psychiatry, clinical child/pediatric/family psychology, pediatrics, social science, and human development. The journal publishes research on diagnosis, assessment, treatment, epidemiology, development, advocacy, training, cultural factors, ethics, policy, and professional issues as related to clinical disorders in children, adolescents, and families. The journal publishes peer-reviewed original empirical research in addition to substantive and theoretical reviews.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信